Vycor Medical, Inc. (VYCO)

Market Cap	3.67M
Revenue (ttm)	1.90M
Net Income (ttm)	-340.85K
Shares Out	33.37M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	720
Average Volume	29,258
Open	0.0760
Previous Close	0.1100
Day's Range	0.0760 - 0.1100
52-Week Range	0.0510 - 0.5000
Beta	-0.28
RSI	41.77
Earnings Date	Mar 27, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VYCO

Financial Performance

In 2024, Vycor Medical's revenue was $1.59 million, an increase of 8.81% compared to the previous year's $1.46 million. Losses were -$431,570, 9.52% more than in 2023.